2007 - rct - Pivotal Reference
Tesamorelin, a Growth Hormone-Releasing Factor Analog, for HIV-Associated Visceral Adiposity
Falutz J et al.. N Engl J Med.
Bibliography For Tesamorelin
Every Curated Peer-Reviewed Reference Indexed For This Compound. Each Citation Can Be Exported In BibTeX, RIS, EndNote, Or Plain Text.
Indexed Types:labelmonographrctstudy
n.d. - label
EGRIFTA SV (TESAMORELIN) KIT [THERATECHNOLOGIES INC.]
Unknown Authors.
n.d. - monograph
RxNorm 1044583 (Tesamorelin)
Unknown Authors.
n.d. - study
Big peptide drugs in a small molecule world.
Unknown Authors.
n.d. - study
Growth hormone and aging: a clinical review.
Unknown Authors.
n.d. - study
Combined antiretroviral therapy with low- or normal-protein, high-calorie diets appears to induce significant deleterious electrocardiographic changes in a rodent model.
Unknown Authors.
n.d. - study
P-1230. Tesamorelin (EGRIFTA WR and EGRIFTA®) Formulations: Bioequivalence in Healthy Participants
Unknown Authors.
n.d. - study
P-1231. A Phase 1 Open-label, Parallel-group, Single-dose Study to Evaluate the Pharmacokinetics and Safety of Obeldesivir in Participants with Normal Renal Function and Renal Impairment
Unknown Authors.
n.d. - study
Adult Growth Hormone Deficiency and Metabolic Dysfunction-Associated Steatotic Liver Disease.
Unknown Authors.
n.d. - study
P-1232. Dose selection of obeldesivir for clinical evaluation in treatment of adult participants with respiratory syncytial virus infection
Unknown Authors.
n.d. - study
P-433. Impact of Tesamorelin on Cardiovascular Disease Risk Prediction Scores in Phase 3 Studies Treatment Arms: Subanalysis
Unknown Authors.
n.d. - study
Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight Loss.
Unknown Authors.
n.d. - study
Facelift as a novel surgical treatment for HIV-associated facial lipodystrophy: a case report and literature review.
Unknown Authors.
n.d. - study
Carpal Tunnel Syndrome Attributed to Medication Use: A Pharmacovigilance Study.
Unknown Authors.
n.d. - study
1499. Tesamorelin Reduces Visceral Adipose Tissue and Liver Fat in INSTI-Treated Persons with HIV
Unknown Authors.
n.d. - study
After the green light: Evaluating drugs in Phase IV studies.
Unknown Authors.
n.d. - study
Growth hormone and nonalcoholic fatty liver disease.
Unknown Authors.
n.d. - study
Growth hormone-releasing hormone attenuates amyloid deposition and neuroinflammation in Alzheimer's disease models.
Unknown Authors.
n.d. - study
Deoxycholic acid treatment for HIV-associated dorsocervical fat pad.
Unknown Authors.
n.d. - study
GHRH in diabetes and metabolism.
Unknown Authors.
n.d. - study
Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.
Unknown Authors.
n.d. - study
Causal association between macrophage migration inhibitory factor and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study.
Unknown Authors.
n.d. - study
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial.
Unknown Authors.
n.d. - study
Lipidization as a tool toward peptide therapeutics.
Unknown Authors.
n.d. - study
Dietary regimens appear to possess significant effects on the development of combined antiretroviral therapy (cART)-associated metabolic syndrome.
Unknown Authors.
n.d. - study
Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin.
Unknown Authors.
n.d. - study
Obesity and Weight Management in HIV: Epidemiology, Complications, and Emerging Treatments.
Unknown Authors.
n.d. - study
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.
Unknown Authors.
n.d. - study
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Unknown Authors.